BioMeter analyzes data from deals

Share this article:

Law firm Morrison & Foerster launched a new quarterly publication, MoFo Biometer, that indexes average up-front payments in licensing, collaboration, and development agreements between biotechnology companies and companies that pay for commercialization rights.

The first edition of the newsletter shows that licensees—the companies paying for commercialization rights to the asset—have generally become more interested in later-stage assets.

In the first quarter of 2012, the biotech market saw increases in the percentage of transactions involving approved products, with average upfront payment values hitting $90 million across 13 transactions.

Between 2006 and 2012, Morrison & Foerster found the average up-front payment in licensing, collaboration, and development agreements was $35.5 million.

The increase is consistent with anecdotal observations, the firm says.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.